Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review

Commonly used clinical strategies against coronavirus disease 19 (COVID-19), including the potential role of monoclonal antibodies for site-specific targeted drug delivery, are discussed here. Solid lipid nanoparticles (SLN) tailored with tocilizumab (TCZ) and loading cannabidiol (CBD) are proposed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zielińska, Aleksandra, Eder, Piotr, Karczewski, Jacek, Szalata, Marlena, Hryhorowicz, Szymon, Wielgus, Karolina, Szalata, Milena, Dobrowolska, Agnieszka, Atanasov, Atanas G., Słomski, Ryszard, Souto, Eliana B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073701/
https://www.ncbi.nlm.nih.gov/pubmed/37033914
http://dx.doi.org/10.3389/fimmu.2023.1147991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073701/
https://www.ncbi.nlm.nih.gov/pubmed/37033914
http://dx.doi.org/10.3389/fimmu.2023.1147991

Ejemplares similares